Directly from the UK: Home Vision Tests Offer Limited Diagnostic Accuracy for Neovascular AMD

No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active neovascular age-related macular degeneration (nAMD), according to a study published online April 25 in JAMA Ophthalmology.

Ruth E. Hogg, Ph.D., from Queen’s University Belfast in the United Kingdom, and colleagues evaluated three vision home-monitoring tests for patients to use to detect active nAMD versus diagnosing active nAMD at hospital follow-up during the after-treatment monitoring phase. The analysis included 259 patients (312 eyes; 50 years of age or older) with at least one eye first treated for active nAMD for six months to 42 months before approach.

Source: Advances and More licensed by HealthDay